STC2 and hypertriglyceridemia: Similarly, Zhao et al. showed that STC2 ameliorated hepatosteatosis and hypertriglyceridemia in obese mice through the activation of Signal transducer and activator of transcription 3 (STAT3) signaling pathway (10).